SFS
XLRN

Sowell Financial Services’s Acceleron Pharma XLRN Stock Holding History

Sowell Financial Services’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-191
Closed -$23K – 3133
2021
Q1 		$23K Sell
191
-30
-14% -$3.88K ﹤0.01% 2015
2020
Q4 		$28K Sell
221
-5
-2% -$586 ﹤0.01% 1610
2020
Q3 		$25K Buy
226
+11
+5% +$1.09K ﹤0.01% 1471
2020
Q2 		$20K Sell
215
-50
-19% -$4.82K ﹤0.01% 1471
2020
Q1 		$24K Sell
265
-1,094
-81% -$85K ﹤0.01% 1337
2019
Q4 		$72K Buy
1,359
+1,130
+493% +$51.5K 0.01% 1013
2019
Q3 		$9K Buy
+229
New +$9.94K ﹤0.01% 1588
2017
Q1 		– Sell
-168
Closed -$5K – 599
2016
Q4 		$5K Buy
+168
New +$5.32K ﹤0.01% 542

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Sowell Financial Services's XLRN Position: Q2 2021 in Review

Sowell Financial Services sold out of Acceleron Pharma (XLRN) in Q2 2021, closing a stake of 191 shares — an estimated $23K sold.

Sowell Financial Services first reported a position in XLRN in Q4 2016 and held it in 8 quarters. The position peaked at $72K in Q4 2019. 271 funds tracked by Wall St. Rank hold XLRN as of Q2 2021.

  • Sowell Financial Services reported no remaining Acceleron Pharma position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 191 Acceleron Pharma shares in Q2 2021, an estimated $23K.
  • Sowell Financial Services first reported a position in Acceleron Pharma in Q4 2016 and held it in 8 quarters.
  • Sowell Financial Services's Acceleron Pharma position peaked at $72K in Q4 2019.
  • 271 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.